Recent advances in the development of allosteric protein tyrosine phosphatase inhibitors for drug discovery

2021 ◽  
Author(s):  
Reham M. Elhassan ◽  
Xuben Hou ◽  
Hao Fang
2020 ◽  
Vol 16 (4) ◽  
pp. 563-574 ◽  
Author(s):  
Rong Y. Han ◽  
Yu Ge ◽  
Ling Zhang ◽  
Qing M. Wang

Background: Protein tyrosine phosphatases 1B are considered to be a desirable validated target for therapeutic development of type II diabetes and obesity. Methods: A new series of imidazolyl flavonoids as potential protein tyrosine phosphatase inhibitors were synthesized and evaluated. Results: Bioactive results indicated that some synthesized compounds exhibited potent protein phosphatase 1B (PTP1B) inhibitory activities at the micromolar range. Especially, compound 8b showed the best inhibitory activity (IC50=1.0 µM) with 15-fold selectivity for PTP1B over the closely related T-cell protein tyrosine phosphatase (TCPTP). Cell viability assays indicated that 8b is cell permeable with lower cytotoxicity. Molecular modeling and dynamics studies revealed the reason for selectivity of PTP1B over TCPTP. Quantum chemical studies were carried out on these compounds to understand the structural features essential for activity. Conclusion: Compound 8b should be a potential selective PTP1B inhibitor.


2005 ◽  
Vol 48 (21) ◽  
pp. 6544-6548 ◽  
Author(s):  
Andrew P. Combs ◽  
Eddy W. Yue ◽  
Michael Bower ◽  
Paul J. Ala ◽  
Brian Wayland ◽  
...  

2007 ◽  
Vol 50 (9) ◽  
pp. 2137-2143 ◽  
Author(s):  
Jesus Vazquez ◽  
Lutz Tautz ◽  
Jennifer J. Ryan ◽  
Kristiina Vuori ◽  
Tomas Mustelin ◽  
...  

ACS Omega ◽  
2020 ◽  
Vol 5 (40) ◽  
pp. 25927-25935
Author(s):  
Runlei Yang ◽  
Qian Dong ◽  
Huibin Xu ◽  
XueHui Gao ◽  
Ziyue Zhao ◽  
...  

2005 ◽  
Vol 15 (18) ◽  
pp. 4037-4042 ◽  
Author(s):  
Kyeong Lee ◽  
Shanthaveerappa K. Boovanahalli ◽  
Ky-Youb Nam ◽  
Sang-Uk Kang ◽  
Mijeoung Lee ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document